Alector, Inc. Common Stock (ALEC)
Alector, Inc. (ALEC) is a biotechnology company focused on discovering and developing immuno-neurology medicines to treat neurodegenerative diseases and cancer. The company's platform leverages insights into the immune system's role in neurodegeneration, aiming to develop targeted therapies for conditions such as Alzheimer’s disease, ALS, and other neuroinflammatory disorders.
Company News
Biotechnology company Alector announced that its drug latozinemab did not meet safety and efficacy criteria in a Phase 3 clinical trial for treating frontotemporal dementia (FTD) caused by GRN gene variants. Despite increasing progranulin protein levels, the drug did not slow disease progression.
Prothena (PRTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module. Airspan Networks Holdings shares surged 381% to $0.3699 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Treasure Glo...